These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 11487740)

  • 1. Yellow mice, red hair, and childhood obesity: the melanocortinergic pathway in energy homeostasis.
    Graham KS; Leibel RL
    J Pediatr; 2001 Aug; 139(2):177-81. PubMed ID: 11487740
    [No Abstract]   [Full Text] [Related]  

  • 2. [From gene defect to drug therapy for obesity?].
    Grünewald-Funk D
    Dtsch Med Wochenschr; 2003 May; 128(19):1034. PubMed ID: 12807110
    [No Abstract]   [Full Text] [Related]  

  • 3. [The central melanocortin system and its role in energy homeostasis].
    Cone RD
    Ann Endocrinol (Paris); 1999 Mar; 60(1):3-9. PubMed ID: 10374010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuronal histamine H(1) and pro-opiomelanocortin-melanocortin 4 receptors: independent regulation of food intake and energy expenditure.
    Yoshimatsu H
    Peptides; 2006 Feb; 27(2):326-32. PubMed ID: 16343692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).
    Challis BG; Coll AP; Yeo GS; Pinnock SB; Dickson SL; Thresher RR; Dixon J; Zahn D; Rochford JJ; White A; Oliver RL; Millington G; Aparicio SA; Colledge WH; Russ AP; Carlton MB; O'Rahilly S
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4695-700. PubMed ID: 15070780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular genetics of the melanocortin pathway and energy homeostasis.
    Leibel RL
    Cell Metab; 2006 Feb; 3(2):79-81. PubMed ID: 16459307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic MSH overexpression attenuates the metabolic effects of a high-fat diet.
    Lee M; Kim A; Chua SC; Obici S; Wardlaw SL
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E121-31. PubMed ID: 17374695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New targets for obesity pharmacotherapy.
    Aronne LJ; Thornton-Jones ZD
    Clin Pharmacol Ther; 2007 May; 81(5):748-52. PubMed ID: 17438540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for beta-melanocyte-stimulating hormone in human body-weight regulation.
    Biebermann H; Castañeda TR; van Landeghem F; von Deimling A; Escher F; Brabant G; Hebebrand J; Hinney A; Tschöp MH; Grüters A; Krude H
    Cell Metab; 2006 Feb; 3(2):141-6. PubMed ID: 16459315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Obesity based on mutation of genes involved in energy balance].
    Hainerová I
    Cas Lek Cesk; 2007; 146(3):240-5. PubMed ID: 17419307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting differentially regulates expression of agouti-related peptide, pro-opiomelanocortin, prepro-orexin, and vasoactive intestinal polypeptide mRNAs in the hypothalamus of Japanese quail.
    Phillips-Singh D; Li Q; Takeuchi S; Ohkubo T; Sharp PJ; Boswell T
    Cell Tissue Res; 2003 Aug; 313(2):217-25. PubMed ID: 12845520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of proopiomelanocortin neurons and peptides in the regulation of energy homeostasis.
    Low MJ
    J Endocrinol Invest; 2004; 27(6 Suppl):95-100. PubMed ID: 15481808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening of mutations in genes of pro-opiomelanocortin in patients with constitutional exogenous obesity].
    Pankov IuA; Iatsyshina SB; Karpova SK; Chekhranova MK; Popova IuP; Grigorian ON; Rogaev EI
    Vopr Med Khim; 2002; 48(1):121-30. PubMed ID: 12068494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of central melanocortin signaling in eating disorders.
    Lu XY
    Psychopharmacol Bull; 2001; 35(4):45-65. PubMed ID: 12397856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pro-opiomelanocortin genes in rainbow trout (Oncorhynchus mykiss): duplications, splice variants, and differential expression.
    Leder EH; Silverstein JT
    J Endocrinol; 2006 Feb; 188(2):355-63. PubMed ID: 16461561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic aspects of human obesity.
    Larder R; Lim CT; Coll AP
    Handb Clin Neurol; 2014; 124():93-106. PubMed ID: 25248581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of red hair phenotype in a North-African obese child homozygous for a novel POMC null mutation: nonsense-mediated decay RNA evaluation and hair pigment chemical analysis.
    Cirillo G; Marini R; Ito S; Wakamatsu K; Scianguetta S; Bizzarri C; Romano A; Grandone A; Perrone L; Cappa M; Miraglia Del Giudice E
    Br J Dermatol; 2012 Dec; 167(6):1393-5. PubMed ID: 22612534
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathophysiology and genetics of obesity].
    Oberkofler H; Krempler F; Patsch W
    Wien Klin Wochenschr; 2002; 114 Suppl 4():4-9. PubMed ID: 15499992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circumventing central leptin resistance: lessons from central leptin and POMC gene delivery.
    Zhang Y; Scarpace PJ
    Peptides; 2006 Feb; 27(2):350-64. PubMed ID: 16274846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of the hypothalamo-pituitary-thyroid axis in the pro-opiomelanocortin deficient mouse.
    Martin NM; Small CJ; Sajedi A; Liao XH; Weiss RE; Gardiner JV; Ghatei MA; Bloom SR
    Regul Pept; 2004 Nov; 122(3):169-72. PubMed ID: 15491787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.